Abstract
In this issue of Blood, Rosen et al evaluate the discordance in factor VIII (FVIII) activity after adenoviral-associated vector (AAV)-gene therapy bet......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
